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Summary 
In addition to T-lineage cells, a small proportion of hematopoietic non-T cells are present in 
the human postnatal thymus. However, the origin of this minor non-T cell thymic compartment 
is presently unknown. In this study we have analyzed the developmental potential of the earliest 
human intrathymic precursors, characterized as CD34 § cells expressing intermediate levels of 
CD44.  We show that these CD34 § CD44 jut thymocytes cultured with interleukin 7 were able 
to develop simultaneously into both T- and non-T (monocytes and dendritic cells) -lineage cells. 
Both developmental pathways progress through a CDI+CD4 §  intermediate stage,  currently 
believed to be the immediate precursor of double positive thymocytes. However, separate progenitors 
for either T  or non-T cells could be characterized within CDI+CD4 + thymocytes by their 
opposite expression of CD44. Downregulated levels of CD44 identified CD1 § CD4 + T-lineage 
precursors,  whereas  CD44  upregulation  occurred on  CDI+CD4 §  intermediates  that  later 
differentiated into non-T cells. Therefore, commitment of human early intrathymic precursors 
to either T or non-T cell lineages can be traced by the differential expression of the CD44 receptor. 
ne marrow-derived hematopoietic precursors homing 
the human thymus have been identified as CD3- 
CD4-CDS-  triple negative (TN) 1 thymocytes (1, 2).  The 
T cell precursor potential of TN thymocytes is confined to 
cells that express CD34 (3), a marker of pluripotent hemato- 
poietic stem cells (4-6). A major question is whether these 
CD34 §  early  thymic immigrants  are  already fully com- 
mitted to the T cell lineage, or whether they represent primi- 
tive precursors that can also give rise to the small percentage 
(<1%) of hematopoietic non-T cells normally present in the 
human postnatal thymus (7-11).  The last possibility is con- 
sistent with the reported presence of myeloid progenitors in 
immature populations of both fetal and neonatal thymocytes 
(1,  12,  13). It is further supported by very recent results 
showing that the human fetal thymus is permissive for the 
development of both lymphoid and myeloid hematopoietic 
lineages derived from fetal liver progenitors (13). However, 
direct evidence that human thymic non-T cells are derived 
from primitive progenitors seeding the thymus is still lacking. 
In contrast, recent studies in mice have shown that the 
first cells in the adult thymus are able to give rise to non-T 
cell lineages. Early postnatal thymocytes (14) were shown to 
1 Abbreviations used in tkispaper: DC, dendritic  calls; DP, double  positive; 
TN, triple negative. 
differentiate into T  cells and dendritic cells (DC) after in- 
trathymic injection (15) and had the capacity to form B and 
NKI.1 + cells in the appropriate environment (16, 17). These 
data suggest that the most immature intrathymic precursors 
represent an intermediate stage between the multipotential 
stem  cells  in  the bone  marrow  and  later  unipotential  T 
cell-committed thymocy,  tes and support their dual potential 
to develop into both lymphoid and nonlymphoid lineages 
(15). At  the present  time,  however,  separate  intrathymic 
precursors for these two developmental pathways remain to 
be identified (14-17). 
Identification of the equivalent precursors in the human 
thymus has been hampered by the lack of in vitro assays to 
assess both  differentiation options.  Since IL-7  is the only 
known factor that does not disrupt the differentiation potential 
of early thymocytes in vitro (18, 19), while maintaining their 
viability (18-21),  this study was aimed at investigating the 
capacity of the earliest CD34 + human intrathymic precursors 
to develop into T and non-T cell lineages when cultured in 
the presence of IL-7. 
Materials and Methods 
Isolation of CD34 + Precursors  from the Human Postnatal Thymus. 
Normal human thymocytes were obtained from thymus fragments 
removed during corrective cardiac surgery of patients aged 1 mo 
475  j. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/95/02/0475/09 $2.00 
Volume 181  February  1995  475--483 to 3 yr. Intrathymic CD3-CD4-CD8-  TN precursors were iso- 
lated as previously described (22). Briefly, cells were treated with 
anti-CD4 (HP2/6),  and -CD8 (B9.4) mAbs plus rabbit comple- 
ment (Sera-Lab Ltd., Sussex, UK).  Anti-CD3  was not included 
in this treatment to avoid the possibility of CD3 capping. After 
Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) centrifugation, re- 
covered viable cells were treated with a cocktail  of anti-CD4, -CD8, 
and -CD3 (SPV-T3b) mAbs followed by two rounds of immuno- 
magnetic bead depletion (Dynabeads; Dynal, Oslo, Norway). In 
some experiments, when a high proportion of mature thymic B 
and NK cells was detected, depletion with anti-CD19 and -CD56 
(Becton Dickinson & Co., San Jose, CA) mAbs was also performed. 
CD34 + cells were then purified from adherent cell-depleted TN 
thymocytes  through positive selection  with CD34-coated immuno- 
magnetic beads (Dynal). 
Immunofluorescence  and Flow Cytometry.  mAbs against the fol- 
lowing antigens were used: CDla (T6-RD1), CD2 (Tll-RD1), 
CDllb (MO1-FITC), and CD14 (MO2-FITC) from Coulter Clone 
(Hialeah, FL); CD3 (Leu-4-PE) from Becton Dickinson & Co.; 
CD4 (Leu-3a-PE or OKT4A-FITC) from Becton Dickinson & Co. 
and Ortho Pharmaceuticals  (Raritan, NJ), respectively;  CD8 (Leu- 
2a-FITC and OKT8-FITC)  from Becton Dickinson & Co. and 
Ortho Pharmaceuticals, respectively; CD7 (Leu-9-FITC), CD13 
(Leu-M7-PE), CD16 (Leu-llc-PE), CD19 (Leu-12-FITC), CD22 
(Leu-14-PE), CD33 (Leu-M9-PE), CD34 (HPCA-2-PE or HPCA- 
2-FITC), CD44 (Leu-44-FITC), CD56 (Leu-19-PE), B7 (BB1), and 
HLA-DR (anti-HLA-DR-PE)  from Becton Dickinson  & Co.; CD21 
(B-E5-FITC) from  Serotec (Oxford,  UK);  and CD23  (IOB8) 
from Immunotech  (Marseille, France). Anti-CD25  (MAR108- 
FITC) and -CD45 (GAP8.3-FITC) have been previously  described 
(23). Anti-CD40  (mAb89) was kindly provided by Dr. J. Ban- 
chereau (Schering-Plough,  Dardilly,  France), and anti-HLA-DP and 
-HLA-DQ were the kind gift of Dr. J. Bodmer (Imperial Cancer 
Research Fund, London, UK). 
Single- and two-color immunofluorescence studies were per- 
formed as described  elsewhere  (23) after incubation of  the cells with 
PBS/EDTA buffer for 15 rain. Stained cells were analyzed in an 
flow cytometer (EPICS Profile; Coulter Electronics Inc., Hialeah, 
FL). Data were collected on 2-5  x  104 viable cells as determined 
by electronic gating  on forward  scatter and  side scatter light 
parameters. Isotype-matched  irrelevant  antibodies  were used to define 
background fluorescence. 
Cell Cultures.  Positively isolated CD34 § thymocytes (1-2  x 
106 m1-1) were cultured at 37~  in 24-well macroplates (Costar, 
Cambridge, MA), in RPMI 1640 (Gihco  Laboratories,  Paisley,  UK), 
10% FCS (Gibco) medium either alone or supplemented with 250 
U/ml of recombinant human IL-7 (rhlU7,  10  s U//~g) (ampoule 
code 90/530; National Institute for Biological  Standards and Con- 
trol, Hertfordshire, UK). Cultures set up either in the presence 
or absence of IL-7 were scored at different times for viable cells 
by trypan blue dye exclusion. 
MLR Assay.  Cells  recovered after 16 d of culture in the pres- 
ence of rhlU7 (>95% large CD44b's  ht) were irradiated (3,500 rads) 
and used at different numbers (30 cells to 2  x  104 cells) as stimu- 
lators for resting allogeneic T cells (2  x  10  s) isolated from periph- 
eral blood. After 5 d of culture in round-bottomed 96-well tissue 
culture plates (Costar) in KPMI 1640 10% FCS, proliferation was 
measured in  triplicate cultures by [3H]thymidine incorporation 
([3H]TdR uptake) after addition of 1 #Ci per well of [3H]TdR. 
(Amersham Corp., Amersham, UK) for the last 4 h. 
Scanning Electron Microscopy.  CD34 § thymocytes  cultured with 
rhlU7 during 12 d were recovered and cultured on glass coverslips 
for an additional 2 d. Adherent cells  were fixed with 3% glutaralde- 
hyde  in 0.1 M cacodylate  buffer,  pH 7.4, washed in the same  buffer, 
and postfixed with 2% OsO4, as previously  described (8). Samples 
were then dehydrated  with graded ethanol series, coated with gold, 
and examined  with a scanning electron microscope (model XL-30; 
Philips, Eindhoven, The Netherlands). 
Results 
Antigenic Phenotype of Human CD34 + Postnatal Thymocytes. 
To investigate the antigenic phenotype of the first hemato- 
poietic precursors  present in the human postnatal thymus, 
CD34 + cells were purified from preparations  of thymocytes 
depleted of cells expressing CD3,  CD4,  or CD8 antigens 
(TN  thymocytes). As  displayed in Fig.  1 A,  TN  thymo- 
cytes were highly enriched (>90%) in cells showing a heter- 
ogeneous (low-to-bright) expression  of the CD34 antigen. 
CD34 + TN thymocytes displayed a low CD45 expression, 
typical for early progenitor cells (6).  A  10-fold higher ex- 
pression of CD45 was detected in a minor fraction (<10%) 
of CD34-  TN thymocytes, which included mature CD7- 
CD22 + B cells and CD7+CD56 + NK cells (Fig.  1 A  and 
data not shown), normally present in the human postnatal 
thymus. In contrast to CD34 + hematopoietic stem cells in 
the bone marrow (6,  24),  intrathymic CD34 + precursors 
coexpressed the CD7 molecule. As described  previously (3, 
20), expression of the CD1 thymic differentiation marker (3, 
6) subdivided CD34 + thymocytes into two different subsets. 
The majority of CD34 + thymocytes (75% in this particu- 
larly experiment) coexpressed CD1, but CD34+CD1 -  cells 
were also consistently detected. According to previous  data 
(3),  we observed  that expression  of CD34  on the CD1- 
CD34 + cells was higher than on CD1 +CD34 + thymocytes 
(Fig. 1 A). Depletion ofTN thymocyte suspensions to elim- 
inate B and NK cells, followed by immunomagnetic selection 
of CD34 + thymocytes, rendered a highly enriched popu- 
lation of cells (0.05-0.1%  of all thymocytes, >98%  pure) 
that displayed high-surface density CD34 (Fig. 1 B). This iso- 
lation technique was found inefficient for selecting CD34 dai 
thymocytes; therefore,  we consistently recovered  cells ex- 
pressing high levels of CD34 (10-15% of total CD34 + TN 
thymocytes in different experiments). As shown in Fig. 1 B, 
these CD34 § thymocytes lacked specific markers of mature 
T (CD3, CD4, CD8) and myeloid (CD14, CD11b) cells. Ex- 
pression  of B- (CD1.9, CD22) and NK-lineage (CD56) an- 
tigens was negative as well (not shown). Positively selected 
CD34 + thymocytes displayed high-surface density CD7 and 
coexpressed  CD2 molecules.  However, expression  of CD1 
was barely detectable in a minor proportion (8% in this ex- 
periment)  of CD34+CD7§  + thymocytes (Fig.  1 B), 
supporting the finding that expression of high levels of CD34 
is mainly confined to CD1-  thymocytes, considered to be 
the most immature intrathymic precursors (3). Further anal- 
ysis of these postnatal CD34 + thymocytes revealed an anti- 
genic phenotype very similar to that of CD34 § early pre- 
cursors present in the fetal thymus (13), including a variable 
expression of low levels of CD33 (20% in this particular ex- 
periment) and the expression  of HLA-DK by most (82%) 
CD34 + cells (Fig.  1 B).  In addition, CD34 + thymocytes 
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Figure  1.  Phenotypic  characterization  of CD34  + 
TN postnatal  thymocytes.  (A) Freshly  isolated post- 
natal TN thymocytes  were  stained  with PE- or FITC- 
coupled anti-CD34 mAbs, and with either FITC- 
labeled anti-CD45, anti-CD7, or PE-labeled  anti-CDla 
mAbs. (B) Positively  selected  CD34  + cells  from the 
TN thymocyte  preparation shown in A were reana- 
lyzed  for the expression  of the indicated  molecules  by 
use of the mAbs described  in Materials  and Methods. 
Background fluorescence  values were set by use of 
isotype-matched  irrelevant mAbs. Results are repre- 
sentative of four independent  experiments. (a.u.) Ar- 
bitrary units. 
coexpressed  intermediate levels of CD44  (CD44int),  a cell 
adhesion/homing molecule mediating extracellular matrix 
binding, which is expressed on hematopoietic precursors  of 
different lineages in both humans and mice (1, 19, 25, 26). 
CD34 +  CD44 int Thymic Precursors Differentiate  into Two Dis- 
tinct  CD34-  Cell  Populations,  One  CD44~g ht,  the  Other 
CD44-,  in the Presence of lL-Z  The developmental poten- 
tial of early CD34 + postnatal thymocytes was analyzed by 
phenotypic studies performed on CD34 § cells cultured in 
the presence  of rhlL-7. CD34 + thymocytes were shown to 
proliferate in an IL-7-dependent manner during the first 3-4 d 
of culture. Results of one representative  experiment (out of 
three) displayed in Fig. 2 show that viable cell numbers in- 
creased about threefold over the initial 3-d culture period and 
was maintained from day 3 to day 6 (cell viability >99%) 
in the presence of IL-7. Thereafter, cellular recovery decreased 
steadily, although a small proportion of viable cells could be 
maintained for up to 2-3 wk. In contrast, cell  viability dropped 
rapidly without IL-7. The proliferative phase of culture was 
accompanied by the appearance  of colonies containing >50 
cells/colony. Nonaggregated smaller round cells were detected 
as well. The size of the colonies decreased throughout cul- 
ture. This was paralleled  by a gradual increase in large,  ir- 
regularly shaped cells within the colonies. To study the pheno- 
typic profile of cells undergoing these morphological changes, 
IL-7-cultured CD34 +  thymocytes were  then analyzed by 
flow cytometry. Since differentiation of mouse CD44 + thy- 
mic progenitors into mature T cells has been shown to pro- 
ceed through an intermediate CD44-  stage (19), we inves- 
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Figure 2.  Cellular yield of cultures of CD34 § thymocytes  supple- 
mented with rhlL-7. A total of 1.8 x 106 CD34  + thymocytes  were cul- 
tured (10 6 cells/ml) either in the absence (D) or presence (II) of rhlL-7 
(250 U/ml). The number of total viable cells recovered at the indicated 
days  was determined  by trypan  blue dye exclusion. Results  are representa- 
tive of three independent experiments. DAY 0 
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Figure  3.  CD34+CD44 i~t thymic precursors cultured with IL-7  differentiate simultaneously into two different subsets of either CD44bng  h~ or CD44- 
cells. CD34+CD44 in' thymic precursors cultured with Ib7 as described in Fig. 2 were analyzed by flow cytometry for the correlated expression of 
CD44 versus CD34 at the indicated days of  culture. Staining was performed  with PE-labeled anti-CD34 and FITC-labded anti-CD44 mAbs. Background 
fluorescence values were set by use of isotype-matched irrelevant mAbs. Results are representative of four independent experiments. 
tigated whether changes in CD44 expression could also define 
control points in the development of human CD34 § thymic 
precursors. As shown in Fig. 3, no significant changes in CD34 
and CD44 expression were detected during the initial (3 d) 
proliferating phase of culture, indicating that IL-7 is a growth 
factor for CD34 § CD44  int human thymocytes. From day 3 
on, however, CD34 was gradually lost, suggesting progres- 
sion through further developmental stages (3, 6, 24, 27). In- 
terestingly,  the decrease in CD34 was accompanied by the 
segregation of CD44  int cells into two different cell popula- 
tions showing opposite CD44 expression. Up- or downregu- 
lation of CD44 was evident in CD34 + cells by day 6 of cul- 
ture,  and resulted in the appearance of two separate subsets 
of CD34-  cells,  one CD44bas  ht,  the other CD44-, by day 
8  (Fig.  3). 
Both CD44- and CD44~g  ht Subpopulations Acquire the CD1 
and CD4  T  Lineage-associated Antigens.  Light-scattering 
analysis of 3-d-cultured CD34 +  CD44  ~t thymocytes revealed 
a  predominant  population  of intermediate-sized  cells  that 
segregated into two separate populations of either small or 
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Figure 4.  Up-  or  downregulation  of CD44  on 
CD34 +  CD44  int thymic  precursors cultured with IL-7 
defines two different populations of  either large or small 
CD1 +  CD4 + thymocytes,  respectively. CD34 +  CD44  int 
thymocytes  cultured with IL-7  were analyzed  for the cor- 
related expression of CD44 versus either CD1 or CD4. 
Two-color flow cytometric studies were performed at 
the indicated days of culture with FITC-labded anti- 
CD44 and either anti-CDla or anti-CD4 PE-coupled 
mAbs. Based  on forward  and side scatter light parameters, 
a single electronic gate was placed in the discrete popu- 
lation of  intermediate sized cells recovered  after 3 or 6 d 
of culture, whereas two different populations of either 
large (L) or small (S) cells were electronically  gated and 
analyzed independently at days 8 and 10. The numbers 
of total viable cells recovered  within the small and large 
subsets were 3.1  x  106 and 0.72  x  10  6, respectively, 
at day 8, and 2.3  x  106 and 0.5  x  10  6,  respectively, 
at day 10. Results are representative of six independent 
experiments. LFS, logarithm of forward scatter; LSS, 
logarithm of side scatter. 
T and Non-T Cell Differentiation from CD34 + Thymic Precursors large cells by day 8  (Fig.  4).  A  close correlation between 
CD44 expression and cell size  could be established when 
electronic gates were placed on the small (80-90%) and large 
(10-20%)  subsets.  CD44-  thymocytes were mainly small 
cells, whereas CD44b~g  h' thymocytes were mostly large cells. 
Changes in CD44 expression were also accompanied by the 
sequential acquisition of antigens  known to be expressed 
early during thymic T cell differentiation. As shown in Fig. 
4, CD1 was the first molecule expressed on cultured CD34 § 
thymocytes. At day 3 of culture, expression of CD1 was ob- 
served in 19% of CD34 + cells. Low levels of CD4 were also 
detected at this time on a small cell fraction (3%  of total 
recovered cells) that coexpressed CD1, indicating that, as pre- 
viously reported (3, 20), CD1 + are the direct precursors of 
CD4 + thymocytes. In fact, most CD1 + cells acquired CD4 
by day 6 (20% CDI+CD4 §  5% CDI+CD4 -, in this ex- 
periment), CD4 § thymocytes becoming a major population 
within both the small (60%) and the large (65%) cell subsets 
by day 8.  However, a subset of CD4 + cells lacking CD1 
molecules (20%) was detected exclusively within the large 
CD44 bright population by day 8. A similar proportion (21%) 
of CD44brightCD4+CD1-  cells  was  detected by  day  10, 
when  essentially all  (96%)  CD44b~g  at  cells  were CD4 § 
Therefore, CD44 i~t thymocytes progressed to more mature 
CD44 b~ight or CD44-  cells  through  a  CDI+CD4 + inter- 
mediate stage. However, high levels of both CD1 and CD4 
molecules were expressed on CD44b~ig  ht cells, whereas inter- 
mediate expression levels of both antigens were consistently 
found in the CD44-  population. 
CD44~ he but Not CD44-  Progeny Derived from  CD34 + 
Precursors Comprise a Mixed Population of Monocytic Cells and 
Dendritic Cells.  To determine the nature of both the large 
CD44bag ht and the small CD44-  populations derived from 
CD34 + thymic precursors, cells were stained with a panel 
of mAbs against distinct lymphoid and myeloid-associated 
markers (Fig.  5 and Table 1). Both the small and the large 
cell subsets were shown to keep CD2 expression at variable 
levels, indicating that  they were derived from intrathymic 
precursors rather than from contaminating peripheral blood 
stem cells (6, 24). However, each population displayed radi- 
cally distinct phenotypic profiles (Fig. 5). Small CD44-  thy- 
mocytes were characterized as T-lineage cells by several criteria: 
(a) they retained a high CD7 expression; (b) they lacked B 
call-, NK cell- (not shown), and myeloid-related antigens, 
as well as HLA class II molecules; and (c) as expected for 
T  cell precursors, they developed into CD4 +  CD8 + double 
positive  (DP)  thymocytes through  a  CDI+CD4 +  transi- 
tional subset (Fig. 5). These DP thymocytes expressed cyto- 
plasmic but not membrane CD3. (not shown), suggesting 
that they represent the immediate precursors of surface CD3 + 
DP thymocytes. This sequence of maturation events corre- 
sponds to that found in vivo for both postnatal and fetal thymic 
precursors differentiating toward mature T cells (3, 20, 27). 
However, no transition to CD3 + T  cells could be detected 
under our culture conditions, since cell viability of CD3- 
DP thymocytes dropped rapidly from day 8 to day 10. This 
suggests that additional signals  to those provided by IL-7, 
most likely involving the participation of the thymic stromal 
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Figure 5.  CD34 § thymic precursors give rise to large CD44bag  ht cells, 
including myelomonocytic cells and DC, and small CD44- T-lineage  cells. 
Large and small cells generated from CD34 § thymic precursors and gated 
as shown in Fig. 4, were analyzed by flow cytometry after 10 d of culture 
in the presence of IL-7. The correlated expression of CD4 versus CD8 
was analyzed by direct  staining with PE-coupled anti-CD4 and FITC- 
coupled anti-CD8 mAbs. Single-color flow cytometry was performed by 
use of FITC-conjugated anti-CD7, anti-CD11b, and anti-CD14 mAbs and 
PE-labeled anti-CD2, anti-CD13, anti-CD33, and anti-HLA-DR mAbs. 
components, are required for terminal differentiation of T 
cell-committed precursors. 
In contrast to CD44-  thymocytes, large CD44bns h' cells 
lacked the CD8 T cell molecule but expressed very high levels 
of CD4 (10-fold higher than CD44-  DP thymocytes) (Fig. 
5). They expressed low CD7 levels, suggesting that CD7 was 
downregulated throughout culture. Most of these cells showed 
high levels of the myeloid-related antigens CDllb,  CD13, 
and CD33,  as well as of HLA-DK,  -DP, and -DQ class II 
molecules,  and many of them were CD14 § (Fig. 5 and Table 
1). This phenotypic pattern closely resembles that recently 
found on myelomonocytic cells derived from CD34 § fetal 
liver precursors in a human fetal thymic organ culture system 
(13). However, >50% of CD44 b~gh' cells shown to express Table  1.  Phenotypic Profile of Large  Cells  Generated from 
Human  CD34 + Thymic Precursors Cultured  with IL-7 
Surface  Fluorescence 
antigens  Positive cells  intensity 
T  cell  antigens  % 
CDla  >80  High 
CD2  >80  Int. 
CD3  <5  Low 
CD4  >95  Int. 
CD7  5-20  Low 
CD8  <5  Low 
B  cell  antigens 
CD19  <5  Low 
CD21  10-30  Low 
CD22  <5  Low 
CD23  20-40  Low 
CD40  40-70  Int. 
CD80  (BT-BB1)  40-60  Int. 
Myeloid antigens 
CDllb  >80  High 
CD13  >80  High 
CD14  60-70  Int-High 
CD33  >80  High 
Class II antigens 
DR  >95  High 
DP  >95  High 
DQ  >95  High 
Other  antigens 
CD16  <5  Low 
CD25  50-60  Int. 
CD44  >95  High 
CD45  >95  High 
CD56  <5  Low 
Large cells (90-95%  of total recovered cells) generated from CD34 + 
thymocytes cultured in the presence of rhlL-7 during 12-16 d were ana- 
lyzed by flow cytometry with the indicated mAbs. Mean of fluorescence 
intensity detected within the second (Low), third (Int.) or fourth (High) 
amplification decades is indicated for each antigen. 
myeloid-related markers  also displayed a  heterogeneous  ex- 
pression  of the  CD23,  CD40,  and  B7  (CD80)  B-lineage 
markers (Table 1). Interestingly, variable levels of these mol- 
ecules have previously been reported in different studies (28-30) 
to be expressed on peripheral Langerhans/DC. Cells displaying 
this  phenotypic  profile could  be maintained  in  culture  for 
up  to  2-3  wk. 
Morphologic  studies of in vitro-derived CD44bng  ht large 
cells revealed a mixed population of adherent and nonadherent 
Figure  6.  Scanning electron micrograph of a CD44~sh~ DC generated 
from IL-7-cultured CD34 + thymocytes. Scanning electron microscopy 
studies were performed on adherent cells derived from CD34 + thymo- 
cytes. Cells cultured with IL-7 during 14 d were treated as described in 
Materials and Methods and analyzed  in a Phillips XL-30  scanning electron 
microscope. Bar, 20/~m. 
cells. Cytospin preparations of nonadherent cells showed the 
presence of ceils with  a  typical monocytic morphology,  as 
well  as  cells  displaying  lobulated  nuclei,  dense  perinuclear 
chromatin,  and  sheet-like  processes characteristic  of Lang- 
erhans/DC (8, 28). The adherent population was also heter- 
ogeneous  and  consisted  of ceils  showing  the  characteristic 
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Figure  7.  Stimulatory capacity of CD44b~sh, cells derived from CD34 + 
thymocytes in an allogeneic MLR.  Cells derived from CD34 + thymo- 
cytes cultured for 16 d with IL-7 (>95%  large CD44b~s  h~) were irradi- 
ated (3,500 tad) and used at different numbers (30 cells to 20  x  103 cells) 
as stimulators for resting allogeneic T cells (2  x  105) isolated from pe- 
ripheral blood. Proliferation after 5 d of culture was measured in triplicate. 
Results are expressed  as mean cpm and are representative  of three different 
experiments. Standard deviations represented <10%  of the mean value. 
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processes. Further examination of these cells by scanning elec- 
tron microscopy revealed a typical dendritic morphology (8, 
28), with a stellate shape and dendritic projections (Fig. 6). 
Finally, functional assays demonstrated the APC capacity of 
the CD44b~ ht cells by showing that they were potent stimu- 
lators of the allogeneic MLP-, (29). Proliferation of allogeneic 
peripheral T  cells  (2  x  105) was increased 40-fold by 104 
CD44b~ ht stimulators (Fig. 7). Therefore, based on morpho- 
logic, phenotypic, and functional criteria (8, 28-30), we can 
conclude that CD44bng  h~ progeny derived from CD34 + pre- 
cursors includes DC as well as monocytic cells. These data 
provide evidence that CD34 § thymocytes are able to differ- 
entiate into non-T cell lineages in the presence of IL-7, sug- 
gesting that lymphoid as well as nonlymphoid cells can be 
newly generated in  the human thymus from intrathymic 
precursors. 
Discussion 
Current in vitro experimental systems for hematopoiesis 
are hampered by the fact that lineage programs undertaken 
by multipotential precursors are influenced by the specific 
growth factors to which they are exposed. However, studies 
in mice have shown that hematopoietic precursors cultured 
with IL-7 retain their intrinsic developmental potential (18, 
19).  In fact,  IL-7 appears to be an important regulator of 
the growth of both T- and B-lymphoid progenitors, (18-21) 
and, recently, a novel role for IL-7 in early myelopoiesis has 
been  reported  (31).  In  this  study,  we  have  analyzed the 
precursor potential of CD34 + human postnatal thymocytes, 
which  are  known  to  represent  the  earliest  intrathymic 
precursors, when cultured in the presence of IL-7. Our results 
revealed the capacity of CD34 + thymocytes to proliferate in 
response to IL-7 and develop simultaneously into T-lineage 
cells, monocytic cells, and DC. Therefore, in addition to its 
reported involvement in early lymphopoiesis and myelopoi- 
esis (18-21,  31),  these data suggest a novel role of IL-7 in 
the development of DC. 
We have shown that IL-7 was able to induce a marked 
proliferation  of CD34 +  thymocytes (which  were  >98% 
pure upon reanalysis)  during the initial 3 d of culture. As 
previously reported (20), IL-7 was also able to maintain the 
viability of CD34 + thymocytes at later periods of culture. 
Phenotypic studies revealed no significant antigenic changes 
during the proliferating phase of culture, indicating that cells 
capable  of responding  to  IL-7  were included within  the 
CD34 § thymic subset. From day 3 on, however, IL-7-cul- 
tured cells sequentially acquired the CD1 and CD4 antigens 
and either myeloid/DC-lineage markers or the CD8 T  cell 
molecule, and CD34 was concurrently downregulated. It is 
thus unlikely that all these phenotypic changes could be ex- 
plained by a selective death of CD34 + thymocytes, or by the 
outgrowth  (from  day  3  on  of culture)  of a  minor  con- 
taminating CD34-  population of already differentiated cells. 
Supporting our findings, it has been previously shown that 
proliferation induced by IL-7, as well as differentiation into 
CD4+CD8 + DP thymocytes, is restricted to the CD34 § 
thymic subset (3, 32). However, no myeloid or DC precursor 
potential was detected in a previous study by Schmitt et al. 
(32) on ex vivo-isolated CD34 § thymocytes cultured in the 
presence of myeloid growth factors. These contradictory results 
may be explained by the heterogeneity of the CD34 + thy- 
mic subset. About 75% of the CD34 + thymocytes reported 
by Schmitt et al.  expressed CD1,  and 30%  of them were 
CD4 +, whereas our preparations were highly enriched in 
CD34bnghtCD1-CD4 -  cells.  These data suggest  that  the 
myeloid/DC precursor potential of CD34 + thymocytes re- 
sides in the CD1-  subset, while most CD34 +  CD1 + thymo- 
cytes may represent T cell-committed precursors. Similarly, 
it has been recently shown that bipotential T/NK cell pro- 
genitors present in the human fetal thymus are confined to 
the CD1-  subset of CD34 bright thymocytes (33).  It is also 
possible that IL-7 [which was omitted in the differentiation 
assay reported by Schmitt et al.  (32)]  is required to induce 
the proliferation and maintain the differentiation potential 
of primitive myeloid/DC intrathymic precursors, whereas 
specific growth factors may be required to drive their ter- 
minal differentiation. This concurs with the observation that 
IL-7 potently enhances the myelopoietic potential of bone 
marrow hematopoietic stem cells,  whereas it has no effect 
on committed myeloid progenitors (31). Supporting this pos- 
sibility,  we have observed that the simultaneous addition of 
IL-7 and GM-CSF to our cultures greatly improved both the 
proportion and survival of DC, as well as of a CD1-  subset 
of CD44b~ightCD4 +  CDllb +DR. + cells,  likely representing 
myelomonocytic precursors (not shown). 
Our results provide evidence for a dual potential of human 
CD34 + thymic precursors  to develop into either T or non-T 
(monocytes and DC) cell lineages, but they do not preclude 
that separate precursors, one for each hematopoietic lineage, 
may be  included within  the CD34 +  thymic population. 
Therefore, we cannot yet conclude that the CD34 + thymic 
subset displays pluripotent hematopoietic activity. Confirma- 
tion of this possibility must await the development of a suit- 
able clonal assay. In our culture conditions, both DC as well 
as T-lineage cells were shown to develop through a CD1 + 
CD4 + intermediate stage.  However, separate precursors for 
either the T  or the DC lineages could be identified at this 
early developmental stage by their differential expression of 
both  CD1  and CD4  markers  (CDlintCD4  int  or  CD1 bright 
CD4brig  ht for T  and DC precursors, respectively). In agree- 
ment with our results, Sotzik et al. (9) have recently reported 
a bright CD4 expression on ex vivo-isolated thymic DC. 
Intrathymic DC, however, did not express CD1, suggesting 
that this molecule is lost in more mature differentiation stages 
in the DC lineage.  We have observed that CD34 §  thymo- 
eytes can also give rise to macrophages, although the exis- 
tence of a CDI+CD4 + intermediate stage in the develop- 
ment of this myeloid lineage remains to be clarified.  It can 
be speculated that, as proposed for bone marrow-derived mac- 
rophages and DC (34), a common bipotential progenitor for 
these two cell lineages exists in the human thymus. 
The simultaneous development of both lymphoid (T cells) 
481  M~rquez  et al. and nonlymphoid (monocytes and DC) lineages from CD34 § 
thymic progenitors allowed us to identify distinctive matu- 
ration events associated with lineage choice in the thymus. 
We have shown that commitment to each alternative develop- 
mental pathway can be traced by the differential expression 
of CD44. Therefore, separate CD1 +CD4 + precursors for ei- 
ther DC  and T  cells can be characterized, respectively,  as 
CD44brig  ht or CD44-  cells. The observation that both cell 
populations do exist in the human postnatal thymus (9, and 
our unpublished results) at a ratio (1-2:10)  similar to that 
found in our in vitro assays provides additional support for 
their physiological relevance in vivo. Indeed, previous results 
in mice have shown that transition from CD44 § to CD44- 
in the thymus is an obligatory step during early T cell differ- 
entiation (13). Whether CD44 expression may also be used 
to identify lymphoid precursors able to give rise to the B 
and/or NK cell intrathymic compartments is currently under 
investigation. 
In light of these studies,  regulation of CD44 expression 
may be envisaged as an early consequence of the developmental 
program undertaken by intrathymic precursors. Alternatively, 
CD44 regulation may play a prominent role in lineage com- 
mitment decisions of putative multipotential hematopoietic 
precursors. Changes in CD44 expression during early thymic 
development may thus be related to differences in the adhe- 
sion requirements to stromal components of distinct thymic 
precursors  and/or the migration patterns of their respective 
progenies. Finally, the reported expression of CD4 molecules 
along the differentiation pathway of both T cells and thymic 
APC (macrophages and DC) has obvious implications for 
the immunopathological consequences of HIV infection (35), 
since either viral carriage by thymic APC or their infection 
would lead to the induction of tolerance in those T cell clones 
specific for viral antigens, thus precluding the induction of 
protective immunity. 
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